As of 2025-07-17, the EV/EBITDA ratio of Dice Therapeutics Inc (DICE) is -28.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DICE's latest enterprise value is 2,170.83 mil USD. DICE's TTM EBITDA according to its financial statements is -77.23 mil USD. Dividing these 2 quantities gives us the above DICE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |